The postmenopausal osteoporosis market is expected to grow significantly during the forecast period (2018-2023). Osteoporosis is a skeletal disorder characterized by skeletal fragility, microarchitectural disruption, and low bone mass. It is a condition where the bone density and bone mass decreases and in the long run increases the risk of bone fracture. The global postmenopausal osteoporosis market is significantly growing due to some factors which include increasing geriatric population. Age is the major factor for the cause of the osteoporosis disease, hence rising geriatric population contributes in the market growth. Factors such as growing prevalence of osteoporosis and developing healthcare infrastructure across the globe also drive the growth of the segment.
Request a free sample of our report on Postmenopausal Osteoporosis Market: https://www.omrglobal.com/request-sample/postmenopausal-osteoporosis-market
Changing lifestyle of people due to consumption of alcohol and smoking, mounting awareness among people through awareness initiatives and programs and continuous innovations in the drugs with the approval by the FDA creates the future opportunity for the growth of the market. On the other hand, there are various factors acting as the barriers for the market which includes the requirement of high standards for the approval of new product launch and increasing competition from the generics.
A full report of Postmenopausal Osteoporosis Market Is available at https://www.omrglobal.com/industry-reports/postmenopausal-osteoporosis-market
Postmenopausal Osteoporosis Market segmentation
By treatment
Bisphosphonates
Hormones
Strontium ranelate
Raloxifene
Denosumab
By distribution channel
Hospital pharmacies
Retail pharmacies
E- commerce pharmacies
Competitive landscape
Key market strategies
Key company analysis
Regional analysis
North america
United states
Canada
Rest of north america
Europe
United kingdom
France
Germany
Italy
Spain
Rest of europe
Asia pacific
India
China
Japan
Rest of the world
Company profiles
Allergan plc
Amgen inc.
Biologicsmd, inc.
Deltanoid pharmaceuticals, inc.
Eli lilly and company
Enteris biopharma, inc.
F. Hoffmann-la roche ltd.
Glaxosmithkline plc
Ligand pharmaceuticals, inc.
Merck & co., inc.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/postmenopausal-osteoporosis-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +91 780-304-0404